|
ANKRD49 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.413440E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.592380E-01 |
| Normal-vs-Stage2 |
1.038790E-01 |
| Normal-vs-Stage3 |
8.417200E-01 |
| Normal-vs-Stage4 |
9.185600E-01 |
| Stage1-vs-Stage2 |
2.395600E-01 |
| Stage1-vs-Stage3 |
2.680400E-01 |
| Stage1-vs-Stage4 |
6.428000E-01 |
| Stage2-vs-Stage3 |
1.000030E-01 |
| Stage2-vs-Stage4 |
2.948000E-01 |
| Stage3-vs-Stage4 |
8.225000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.286800E-01 |
| Normal-vs-AfricanAmerican |
1.241390E-01 |
| Normal-vs-Asian |
6.110400E-01 |
| Caucasian-vs-AfricanAmerican |
3.991000E-01 |
| Caucasian-vs-Asian |
7.439000E-01 |
| AfricanAmerican-vs-Asian |
8.063200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.375800E-01 |
| Normal-vs-Female |
5.460300E-02 |
| Male-vs-Female |
1.553020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.515400E-01 |
| Normal-vs-Extreme_Weight |
4.375600E-01 |
| Normal-vs-Obese |
4.478200E-01 |
| Normal-vs-Extreme_Obese |
6.348400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.491800E-01 |
| Normal_Weight-vs-Obese |
7.842200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.197800E-01 |
| Extreme_Weight-vs-Obese |
9.712400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.705400E-01 |
| Obese-vs-Extreme_Obese |
7.886600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.415420E-01 |
| Normal-vs-Age(41-60Yrs) |
1.295800E-02 |
| Normal-vs-Age(61-80Yrs) |
7.946200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.613900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.226000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.946500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.319500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.392400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.268200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.943190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.936000E-02 |
| Normal-VS-Type2 PRCC |
1.919580E-01 |
| Normal-VS-KIRP CIMP |
6.878000E-01 |
| Normal-VS-Unclassified PRCC |
8.802100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.098760E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.350600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.160400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.942200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.785780E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.213800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.705000E-01 |
| Normal-vs-N1 |
3.900200E-01 |
| Normal-vs-N2 |
4.963200E-04 |
| N0-vs-N1 |
7.295200E-01 |
| N0-vs-N2 |
5.98600000000227E-05 |
| N1-vs-N2 |
7.480000E-03 |
|
|
